C4a Lav-freeze 42658 279.8, Recheck C3a 286.5, in and C4a (not 710.0, monthly in Futhan) 780.79 treatment of lowered PSL, consider by VIP high-dose therapy & statins with Rx for CoQa in PSL CIRS, increases within 12 hours IgE SST-freeze 542x 493.01 33 Consider Good indicator U/ml VIP of mycotoxins, therapy; fog, Capillary Hypoperfusion 8,000 units for 5 doses Lyme LabCorp SST-freeze or WB 780.79 (RS) CD4+ LabCorp lav-room 505008 temp 505008 286.5, CD25+ 279.8 Lipase SST-freeze 606x 577.8, Low with 780.79 high TGF β-1 Summarized Treatment Overview; Remove from exposure Cholestyramine for 30 days Actos run-up if Lyme) Eradicate biofilm formers/MARCoNS No gluten if AGA (+) Do Tissue Trans Glutaminase IgA, IgG, IgM if Gluten (+) Expect to find more of the IgG than IgM but measure all 3 Actos/low Amylose diet for MMP9, PAI-1, Leptin Correct ADH/Osmolality; Use if abnormal Androgens; Look at Testosterone/Estrogen to determine if up-regulated Consider DHEA Sulfate to correct from “upstream” Avoid Aromatase Inhibitors Fix C3a, C4a, TGF β-1
C4a (not Futhan) Lav-freeze 42658 279.8, 286.5, 710.0, 780.79 in lowered by VIP therapy & Rx for CIRS, increases within 12 hours Recheck C3a and C4a monthly in treatment of PSL, consider high-dose statins with CoQa in PSL IgE SST-freeze 542x 493.01 33 U/ml Consider VIP therapy; 8,000 units for 5 doses Good indicator of mycotoxins, fog, Capillary Hypoperfusion Lyme WB (RS) LabCorp or SST-freeze 780.79 CD4+ 505008 CD25+ LabCorp 505008 lav-room temp 286.5, 279.8 Lipase SST-freeze 606x 577.8, 780.79 Low with high TGF β-1 Summarized Treatment Overview; Remove from exposure Cholestyramine for 30 days Actos run-up if Lyme) Eradicate biofilm formers/MARCoNS No gluten if AGA (+) Do Tissue Trans Glutaminase IgA, IgG, IgM if Gluten (+) Expect to find more of the IgG than IgM but measure all 3 Actos/low Amylose diet for MMP9, PAI-1, Leptin Correct ADH/Osmolality; Use if abnormal Androgens; Look at Testosterone/Estrogen to determine if up-regulated Consider DHEA Sulfate to correct from “upstream” Avoid Aromatase Inhibitors Fix C3a, C4a, TGF β-1
CIRS_Overview.docx